TGFB1 and hepatocellular carcinoma: Analogous to RUNX3, TGF-β treatment enhances ZEB2 expression in MPs in the context of human hepatocellular carcinoma, suggesting possible co-regulation of both transcription factors through TGF-β-mediated signaling (74).